ES2184805T3 - Procedimiento para producir y cultivar celulasd precursoras hematopyeticas. - Google Patents

Procedimiento para producir y cultivar celulasd precursoras hematopyeticas.

Info

Publication number
ES2184805T3
ES2184805T3 ES95925778T ES95925778T ES2184805T3 ES 2184805 T3 ES2184805 T3 ES 2184805T3 ES 95925778 T ES95925778 T ES 95925778T ES 95925778 T ES95925778 T ES 95925778T ES 2184805 T3 ES2184805 T3 ES 2184805T3
Authority
ES
Spain
Prior art keywords
pct
hematopyetic
cultivating
procedure
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95925778T
Other languages
English (en)
Inventor
Hartmut Beug
Oliver Wessely
Peter Steinlein
Eva Deiner
Lindern Maartje Marie Von
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Application granted granted Critical
Publication of ES2184805T3 publication Critical patent/ES2184805T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0641—Erythrocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/148—Transforming growth factor alpha [TGF-a]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C12N2501/392—Sexual steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA LA PRODUCCION IN VITRO DE CELULAS PRECURSORAS HEMATOPOYETICAS DE LA LINEA ERITROIDEA, EN LA CUAL UNA POBLACION DE CELULAS PRECURSORAS ERITROIDEAS SE EXPONE A UNA COMBINACION DE FACTORES DE CRECIMIENTO, QUE CONTIENEN UN GLUCOCORTICOIDE Y UN ESTROGENO , Y AL MENOS UN LIGANDO DE UN RECEPTOR DE UNA TIROSINA-QUINASA, HASTA QUE LAS CELULAS EMPIEZAN ELLAS MISMAS A RENOVARSE
ES95925778T 1994-06-30 1995-06-28 Procedimiento para producir y cultivar celulasd precursoras hematopyeticas. Expired - Lifetime ES2184805T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4422667A DE4422667A1 (de) 1994-06-30 1994-06-30 Verfahren zur Herstellung und Züchtung hämatopoetischer Vorläuferzellen

Publications (1)

Publication Number Publication Date
ES2184805T3 true ES2184805T3 (es) 2003-04-16

Family

ID=6521750

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95925778T Expired - Lifetime ES2184805T3 (es) 1994-06-30 1995-06-28 Procedimiento para producir y cultivar celulasd precursoras hematopyeticas.

Country Status (10)

Country Link
US (1) US5905041A (es)
EP (1) EP0716689B1 (es)
JP (1) JPH09502359A (es)
AT (1) ATE225396T1 (es)
CA (1) CA2170642A1 (es)
DE (2) DE4422667A1 (es)
DK (1) DK0716689T3 (es)
ES (1) ES2184805T3 (es)
PT (1) PT716689E (es)
WO (1) WO1996000777A1 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2794473B1 (fr) * 1999-06-03 2003-09-26 Centre Nat Rech Scient Procede de multiplication de cellules souches
ATE373421T1 (de) * 1999-06-29 2007-10-15 Univ Leland Stanford Junior Untereinheiten von myeloid-progenitorzellen von säugern
US6761883B2 (en) * 1999-06-29 2004-07-13 The Board Of Trustees Of The Leland Stanford Junior University Mammalian myeloid progenitor cell subsets
WO2002046373A1 (en) * 2000-12-06 2002-06-13 Hariri Robert J Method of collecting placental stem cells
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
EP2336299A1 (en) * 2001-02-14 2011-06-22 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
US20050019910A1 (en) * 2001-12-13 2005-01-27 Mutsumi Takagi Human cell culture medium and culture method
AU2003295444A1 (en) * 2002-11-15 2004-06-15 The Board Of Trustees Of The University Of Illinois Methods for in vitro expansion of hematopoietic stem cells
EP1571910A4 (en) 2002-11-26 2009-10-28 Anthrogenesis Corp CYTOTHERAPEUTIC AGENTS, CYTOTHERAPEUTIC UNITS AND METHODS OF TREATMENT IN WHICH THEY INTERVENE
AU2004227205B2 (en) * 2003-04-08 2010-06-10 Yeda Research And Development Co. Ltd Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same
US20050265980A1 (en) 2004-05-14 2005-12-01 Becton, Dickinson And Company Cell culture environments for the serum-free expansion of mesenchymal stem cells
ZA200704252B (en) 2004-10-25 2009-09-30 Cellerant Therapeutics Inc Methods of expanding myeloid cell populations and uses thereof
WO2006055841A2 (en) * 2004-11-19 2006-05-26 University Of Florida Research Foundation, Inc. Indefinite culture of human adult glia without immortalization and therapeutic uses thereof
WO2007047468A2 (en) 2005-10-13 2007-04-26 Anthrogenesis Corporation Immunomodulation using placental stem cells
ZA200804718B (en) 2005-12-29 2010-04-28 Anthrogenesis Corp Co-culture of placental stem cells and stem cells from a second source
NZ595786A (en) 2005-12-29 2013-05-31 Anthrogenesis Corp Placental stem cell populations
EP2129775A1 (en) * 2007-02-12 2009-12-09 Anthrogenesis Corporation Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
EP2630959A1 (en) 2007-02-12 2013-08-28 Anthrogenesis Corporation Treatment of inflammatory diseases using placental stem cells
TWM322542U (en) * 2007-05-23 2007-11-21 Universal Scient Ind Co Ltd Testing machine
US9200253B1 (en) 2007-08-06 2015-12-01 Anthrogenesis Corporation Method of producing erythrocytes
KR20230065354A (ko) 2007-09-28 2023-05-11 셀룰래리티 인코포레이티드 인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법
PE20110399A1 (es) * 2008-08-20 2011-06-22 Anthrogenesis Corp Tratamiento de la apoplejia utilizando celulas placentarias aisladas
CA2734236C (en) 2008-08-20 2020-08-25 Anthrogenesis Corporation Improved cell composition and methods of making the same
NZ591293A (en) 2008-08-22 2012-10-26 Anthrogenesis Corp Methods and compositions for treatment of bone defects with osteogenic placental adherent cells (OPACs)
NZ602455A (en) 2008-11-19 2014-03-28 Anthrogenesis Corp Amnion derived adherent cells
AU2010266263B2 (en) * 2009-07-02 2016-05-19 Celularity Inc. Method of producing erythrocytes without feeder cells
CA2787992A1 (en) 2010-01-26 2011-08-04 Anthrogenesis Corporation Treatment of bone-related cancers using placental stem cells
US20130059783A1 (en) * 2010-03-12 2013-03-07 Johan Flygare Compositions and methods for expanding bfu-e cells
KR20200047797A (ko) 2010-04-07 2020-05-07 안트로제네시스 코포레이션 태반 줄기 세포를 사용한 혈관신생
CN102933221A (zh) 2010-04-08 2013-02-13 人类起源公司 使用胎盘干细胞治疗结节病
KR20230096132A (ko) 2010-07-13 2023-06-29 셀룰래리티 인코포레이티드 천연 킬러 세포의 생성 방법
US8969315B2 (en) 2010-12-31 2015-03-03 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
ES2707579T3 (es) 2011-06-01 2019-04-04 Celularity Inc Tratamiento del dolor usando citoblastos placentarios
US9925221B2 (en) 2011-09-09 2018-03-27 Celularity, Inc. Treatment of amyotrophic lateral sclerosis using placental stem cells
EP3622960A1 (en) 2013-02-05 2020-03-18 Celularity, Inc. Natural killer cells from placenta
EP2997135B1 (en) * 2013-05-15 2020-04-29 University Of Rochester Human extensively self-renewing erythroblasts (esre)
CN109415680B (zh) 2016-05-18 2022-08-16 学校法人庆应义塾 类器官培养用细胞培养基、培养方法及类器官

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399493A (en) * 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5270458A (en) * 1991-04-02 1993-12-14 The Trustees Of Princeton University Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2
WO1993018136A1 (en) * 1992-03-05 1993-09-16 Cytomed, Inc. Process for supporting hematopoietic progenitor cells
WO1993025216A1 (en) * 1992-06-08 1993-12-23 Becton, Dickinson And Company Human primitive stem cells
WO1994008039A1 (en) * 1992-10-02 1994-04-14 Systemix, Inc. Method of enrichment for human hematopoietic stem cells using c-kit
US5405772A (en) * 1993-06-18 1995-04-11 Amgen Inc. Medium for long-term proliferation and development of cells

Also Published As

Publication number Publication date
EP0716689B1 (de) 2002-10-02
JPH09502359A (ja) 1997-03-11
DE4422667A1 (de) 1996-01-04
WO1996000777A1 (de) 1996-01-11
CA2170642A1 (en) 1996-01-11
EP0716689A1 (de) 1996-06-19
US5905041A (en) 1999-05-18
PT716689E (pt) 2003-02-28
ATE225396T1 (de) 2002-10-15
DK0716689T3 (da) 2003-01-27
DE59510402D1 (de) 2002-11-07

Similar Documents

Publication Publication Date Title
ES2184805T3 (es) Procedimiento para producir y cultivar celulasd precursoras hematopyeticas.
DE69228197D1 (de) Silikondioxid enthaltendes produkt und seine herstellung
ES542979A0 (es) Procedimiento para preparar 6-aril-3 2h piridazinonas
DE59109027D1 (en) Arylpyridazinone
IL116385A0 (en) Sulphonamides their manufacture and pharmaceutical compositions containing them
DE69608915T2 (de) Herstellung von dimethylether mit kraftstoffreinheitsgrad
JP2003513664A5 (es)
ATE112239T1 (de) Vaterit und verfahren zu dessen herstellung.
DK0701604T3 (da) Immortalisering af dendritiske celler med V-myc-onkogenet
DE69530589D1 (de) Alginatfasern, herstellung und verwendung
ATE198316T1 (de) N-bis- oder n-tris-((1,2-dicarboxy-ethoxy)-ethyl)-amin-deri ate und herstellung und anwendung derselben
MX9701087A (es) Procedimiento novedoso para la preparacion de diisopinoalcanforilcloroborano.
ES8307886A1 (es) "procedimiento para la fabricacion de combustibles para motores diesel".
ES2017279A6 (es) Procedimiento para la obtencion de piperazinas y homopiperazinas substituidas.
MX9600735A (es) Procedimiento para la produccion y cultivo de celulas precursoras hematopoyeticas.
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
DK0804450T3 (da) Fremgangsmåde til fremstilling af palatinitol
ES543383A0 (es) Mejoras en un procedimiento para la preparacion de rimanta- dina
DE69618340T2 (de) Verfahren zur herstellung von substituierten anthrachinonen und deren verwendung zur herstellung von rheinen
FI920268A (fi) Tricykliskt pyridonderivat.
Rein et al. Factors affecting the growth and maintenance of human skin mast cells in cell culture
Zhe-zhi et al. Variation and high frequency somatic embryogenesis of embryogenic callus in Gossypium hirsutum
IT1249599B (it) Metodo per produrre un supporto per disegno
HUT77240A (hu) 4,4'-Metilén-bisz(3-klór-2,6-dialkil-fenil-izocianát)-vegyületek, ezek előállítása és alkalmazása poliuretánrendszerek előállítására, valamint a poliuretánrendszerek
Seligmann et al. Breaking tradition at the Citadel.